The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ISLB 2021 | Challenges for the implementation of liquid biopsy in NSCLC

Name: Challenges for the implementation of liquid biopsy in NSCLC
Uploaded: 2021-10-28T00:00:00Z
Duration: 1 min 36 s
Description: David Gandara, MD, UC Davis Comprehensive Cancer Center, Sacramento, CA, discusses the challenges that need to be overcome in order to fully implement liquid biopsy in healthcare systems around the world. This interview took place at the International Society of Liquid Biopsy 2021 Virtual Meeting.

David Gandara • 28 Oct 2021

ISLB 2021

Lung Cancer Non-Small Cell Lung Cancer

David Gandara, MD, UC Davis Comprehensive Cancer Center, Sacramento, CA, discusses the challenges that need to be overcome in order to fully implement liquid biopsy in healthcare systems around the world. This interview took place at the International Society of Liquid Biopsy 2021 Virtual Meeting.